Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
Authors
Keywords
-
Journal
LANCET INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-11-25
DOI
10.1016/s1473-3099(22)00729-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
- (2022) Zhen Cui et al. CELL
- Effectiveness of COVID-19 booster vaccines against covid-19 related symptoms, hospitalisation and death in England
- (2022) Nick Andrews et al. NATURE MEDICINE
- Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England”
- (2022) Borbàla Zsigmond et al. JOURNAL OF INFECTION
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
- (2022) Tommy Nyberg et al. LANCET
- Effectiveness of BNT162b2 against COVID-19 in adolescents
- (2022) Annabel A Powell et al. LANCET INFECTIOUS DISEASES
- COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
- (2022) Freja C M Kirsebom et al. LANCET INFECTIOUS DISEASES
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
- (2022) Yair Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- BNT162b2 Protection against the Omicron Variant in Children and Adolescents
- (2022) Ashley M. Price et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
- (2022) Kerstin Kläser et al. Scientific Reports
- COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar
- (2022) Adeel A Butt et al. Journal of Global Health
- Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021
- (2021) Miranda J. Delahoy et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
- (2021) Laith J. Abu-Raddad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 in children: analysis of the first pandemic peak in England
- (2020) Shamez N Ladhani et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now